Creating lasting positive impacts on the world by reimagining possibilities and solving complex problems

2Q24 Highlight: Vedanta

The human body is an ecosystem. Trillions of microbes call us home. They form the human microbiome, which performs critical functions that preserve our health including modulating our immune system and providing colonization resistance against infectious pathogens. Alterations of the human microbiome are increasingly recognized as a key factor in development of immune and infectious diseases.

Vedanta rationally designs medicines based on consortia of human commensal bacteria to treat a range of gastrointestinal diseases, using insights from microbial ecology, mucosal immunology, and human interventional studies. The highly technical and visionary team at Vedanta has spent years perfecting the process necessary to deliver consistent, standardized pharmaceutical-grade drug product based on defined bacterial consortia, and is on the cusp of forever changing how we treat immune and infectious diseases in the human gut.